Education
About Us
Working with TipRanks
Follow Us
John Aplin Insider Profile
4 Followers
John Aplin, Director at Endocyte, holds 0.00 shares in Endocyte (Ticker: ECYT), holds 6.94K shares in Stereotaxis (Ticker: STXS).
John Aplin Endocyte (ECYT)Director
Endocyte (ECYT)
Director
Not Ranked
John Aplin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that John Aplin holds in companies
Most Profitable Insider Trade
Stock:
Endocyte
(ECYT)
(ECYT)
Rating:Informative Buy
Date:Dec 16, 2011 - Dec 16, 2012
Return:+217.90%
The most profitable trade made by John Aplin
John Aplin's Trading History
Endocyte
Dec 21, 2018
―
Uninformative Sell
692.71K
$0.00
Stereotaxis
―
Director
―
$12.99K
List of latest transactions for each holding click on a transaction to see John Aplin's performance on stock
You May Also Like
John Aplin insider profile FAQ
What is the percentage of profitable transactions made by John Aplin?
The percentage of profitable transactions made by John Aplin is ―.
What is the average return per transaction made by John Aplin?
The average return per transaction made by John Aplin is ―.
What stocks does John Aplin hold?
John Aplin holds: ECYT, STXS stocks.
What was John Aplin’s latest transaction?
John Aplin latest transaction was an Uninformative Sell of $692.71K.
What was John Aplin's most profitable transaction?
John Aplin’s most profitable transaction was an Informative Buy of ECYT stock on December 16, 2011. The return on the trade was 217.90%.
What is John Aplin's role in Endocyte?
John Aplin's role in Endocyte is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.